Edition:
India

Bio Rad Laboratories Inc (BIO.N)

BIO.N on New York Stock Exchange

277.62USD
12:38am IST
Change (% chg)

$4.40 (+1.61%)
Prev Close
$273.22
Open
$271.31
Day's High
$279.04
Day's Low
$271.31
Volume
11,487
Avg. Vol
32,692
52-wk High
$345.15
52-wk Low
$231.28

Latest Key Developments (Source: Significant Developments)

Bio-Rad Q3 Non-Gaap Earnings Per Share $0.91
Friday, 2 Nov 2018 

Nov 1 (Reuters) - Bio Rad Laboratories Inc ::BIO-RAD REPORTS THIRD-QUARTER 2018 FINANCIAL RESULTS.Q3 NON-GAAP EARNINGS PER SHARE $0.91.Q3 EARNINGS PER SHARE $8.89.Q3 SALES $545.1 MILLION VERSUS I/B/E/S VIEW $538.7 MILLION.Q3 EARNINGS PER SHARE VIEW $1.15 -- THOMSON REUTERS I/B/E/S.FOR FULL YEAR 2018, COMPANY IS REITERATING PREVIOUS CURRENCY-NEUTRAL GROWTH REVENUE OUTLOOK OF 4.0 TO 4.5 PERCENT.  Full Article

Bio Rad Laboratories Says KPMG Notified Senior Management It Required More Time To Complete Audit Of 2017 Financial Statements
Friday, 16 Mar 2018 

March 16 (Reuters) - Bio Rad Laboratories Inc ::BIO RAD LABORATORIES - KPMG NOTIFIED SENIOR MANAGEMENT IT REQUIRED MORE TIME TO COMPLETE AUDIT OF 2017 FINANCIAL STATEMENTS - SEC FILING.BIO RAD LABORATORIES SAYS UNABLE TO FILE 2017 FORM 10-K BY EXTENDED FILING DEADLINE OF MARCH 16.BIO RAD LABORATORIES SAYS IDENTIFIED CERTAIN INTERNAL CONTROL DEFICIENCIES ARISING FROM APRIL 2017 ERP SYSTEM & BUSINESS STRUCTURE CONVERSION.BIO RAD LABORATORIES - CONCLUDED THAT INTERNAL CONTROL OVER FINANCIAL REPORTING WAS NOT EFFECTIVE AS OF DEC 31, 2017.  Full Article

Bio-Rad Q4 Earnings Per Share $2.32
Wednesday, 28 Feb 2018 

Feb 27 (Reuters) - Bio Rad Laboratories Inc ::BIO-RAD REPORTS FOURTH-QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS.Q4 EARNINGS PER SHARE $2.32.Q4 SALES ROSE 8.6 PERCENT TO $620.4 MILLION.‍FOR FULL YEAR 2018, COMPANY ANTICIPATES CURRENCY NEUTRAL REVENUE GROWTH OF APPROXIMATELY 3.5 PERCENT TO 4.0 PERCENT ​.‍FOR FULL YEAR 2018, ANTICIPATES IMPROVED PROFITABILITY WITH CURRENCY NEUTRAL OPERATING MARGIN TARGET OF 10 PERCENT​.  Full Article

Bio-Rad Authorizes New $250 Million Share Repurchase Program
Tuesday, 28 Nov 2017 

Nov 28 (Reuters) - Bio Rad Laboratories Inc ::BIO-RAD AUTHORIZES NEW $250 MILLION SHARE REPURCHASE PROGRAM.BIO RAD LABORATORIES INC - ‍NEW SHARE REPURCHASE PROGRAM SUPERSEDES COMPANY'S PRIOR SHARE REPURCHASE PROGRAM​.  Full Article

Bio Rad Laboratories reports Q3 earnings per share $0.91
Friday, 3 Nov 2017 

Nov 2 (Reuters) - Bio Rad Laboratories Inc :Bio Rad Laboratories Inc reports third-quarter 2017 financial results.Q3 earnings per share $0.91.Q3 sales $535 million versus I/B/E/S view $508 million.Sees q4 2017 sales $615 million to $625 million.Q3 earnings per share view $0.38 -- Thomson Reuters I/B/E/S.  Full Article